Comparing the Incidence of Parastomal Hernia After Mesenteric Molding Suturing and Non-molding Suturing in Colostomy Surgery

Launched by THE FIRST AFFILIATED HOSPITAL WITH NANJING MEDICAL UNIVERSITY · Nov 4, 2024

Keywords

ClinConnect Summary

This clinical trial is studying two different surgical techniques used during colostomy surgery to see which one better prevents a common complication called parastomal hernia (PSH). A parastomal hernia occurs when tissue pushes through the abdominal wall around the stoma (the opening created during colostomy surgery). Researchers want to find out if a newer method called mesenteric molding suturing is more effective than the traditional non-molding suturing technique in reducing the incidence of PSH. This is important because PSH can lead to pain, problems with the stoma, and the need for additional surgeries.

To participate in this study, individuals must be 18 years or older and require colostomy surgery. They should also be able to provide informed consent and have an expected survival of more than one year. However, those with severe health issues, pregnant or breastfeeding women, and individuals with certain mental health conditions are not eligible. Participants can expect to undergo the surgery and be monitored afterward to assess the results and any complications related to the different suturing techniques. This trial aims to improve patient outcomes and quality of life following colostomy surgery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age 18 years or older.
• • Patients requiring colostomy surgery.
• • Ability to provide written informed consent.
• • Expected survival of more than one year.
• • No severe comorbidities such as heart, lung, liver, or kidney dysfunction.
• Exclusion Criteria:
• • Pregnant or breastfeeding women.
• • History of major abdominal surgery that could affect the development of PSH.
• • Mental illness that impairs understanding of the study content and ability to give informed consent.
• • Patients receiving immunosuppressive therapy or chemotherapy.